Clinical Trial Update: Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update for Octafibrin in on-demand treatment of acute bleeding and perioperative prophylaxis in congenital fibrinogen deficiency; results posted, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Fibrinogen Deficiency

Drugs mentioned

• Octafibrin

Snippet

Sponsor: Octapharma | Conditions: Congenital Fibrinogen Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2019-02-20